Robinhood price target lowered to $26 from $35 at JPMorgan 07:42 HOOD
Sorry about you guy's friend Stoney. So much research is being done, and tech has enabled exponential leaps in the fight. Someone asked me a while back if I thought their was any type of conspiracy to keep keep new treatments down, they knew I am into stocks and company research. I told them "I don't know". And I don't.Robinhood price target lowered to $26 from $35 at JPMorgan 07:42 HOOD
Doesn't heart disease kill more people?If there was no cancer there would be no room in the world and no food.
Would you eat the fish in that pond?Ahhhh.... who knows.
New segment.
BASF raises full-year guidance despite seeing continued bottlenecks
Oct. 27, 2021
![]()
- BASF(OTCQX:BASFY)raises its FY 2021 guidance after saying it generated strong sales growth in Q3, but shares trade ~1% lower in Europe.
- The company said that despite supply bottlenecks, it expects full-year revenues to rise to a range of €76B-€78B from prior guidance of €74B-€77B.
- BASF also guides for FY 2021 adjusted EBIT of €7.5B-€8B vs. its prior forecast for €7B-€7.5B.
- For Q3, BASF swung to a net profit of €1.25B from a net loss of €2.12B in the year-earlier quarter.
- Q3 revenues rose 42% Y/Y to €19.67B, above analyst consensus estimate, as the company raised prices by 36% on average and volumes by 6% from a year earlier.
- But BASF said growth momentum slowed compared with Q2due to supply bottlenecks, particularly with chip shortages in the automotive business.
- The company believes supply chain holdups will continue to weigh on the global economy through the end of the year, but it nevertheless expects continuing solid demand, prompting the guidance boost.